Skip to content

Comparative Study Between the Efficacy Of Guduchyadi Taila Uttarbasti and Dashmool Taila Uttarbasti in Udavarta Yonivyapad.

A Randomised Comparative Clinical Study Of Efficacy Of Guduchyadi Taila Uttarbasti and Dashmool Taila Uttarbasti in Udavarta Yonivyapad.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/028971
Enrollment
68
Registered
2020-11-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Guduchyadi taila uttarbasti: Guduchyadi taila will be purchased from GMP certified pharmacy and uttar basti will be given to females in the age group of 20-40 years in 5 ml matra for 3

Sponsors

Principal PDEAs college of ayurved and research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients fulfilling the diagnostic criteria. 2.Patient age group between 20 to 40 years. 3.Patients with regular menstrual cycles(21-35days is the normal menstrual cycle). 4.Painful menstruation for at least 3 consecutive cycles. 5.Patient willingly participating in the trials and giving consent form

Exclusion criteria

Exclusion criteria: 1.Cases of Secondary dysmenorrhoea with pelvic pathology- Fibroid of Uterus, Ovarian cyst, Endometriosis, Endometrial hyperplasia. 2.Irregular menstrual cycle, metrorrhagia, menorrhagia. 3.Patient with IUCD. 4.Patients on hormonal therapy. 5.Patients having congenital anomalies leading to dysmenorrhoea. 6.Patients with systemic disease disorders like DM, HTN etc. 7.Antenatal and postnatal.

Design outcomes

Primary

MeasureTime frame
To compare efficacy of Guduchyadi taila uttarbasti and dashmool taila uttarbasti in udavarta yonivyapad for 3 consecutive days after cessation of menstrual bleeding.Timepoint: 3 consecutive days after cessation of menstrual bleeding for 3 consecutive menstrual cycles.

Secondary

MeasureTime frame
To study any adverse effect of Guduchyadi taila uttarbasti and Dashmool taila uttarbastiTimepoint: 3 consecutive days after cessation of menstrual bleeding for 3 consecutive menstrual cycles.

Countries

India

Contacts

Public ContactDr Priyanka Machindra Rakh

PDEAs college of ayurved and research center,Nigadi Pradhikaran,Pune

anjalivijayjadhav@gmail.com9850808899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026